Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
NCT02021604
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Congenital Hyperinsulinism
Insulinoma
Interventions
DRUG:
Fluorodopa F 18
Sponsor
Cook Children's Health Care System